Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficiency (Details Narrative)

v3.5.0.2
Stockholders' Deficiency (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended
Mar. 24, 2016
Mar. 11, 2016
Jul. 28, 2015
Aug. 07, 2014
Mar. 31, 2016
Mar. 31, 2016
Dec. 31, 2015
Mar. 31, 2015
Jan. 31, 2016
Cash payment of settlement     $ 737,425 $ 112,500          
Accrued expenses             $ 20,991    
Number of warrants issued to purchase of common stock shares         1,904,857 1,904,857     1,290,000
Warrants exercise price per share         $ 1.00 $ 1.00     $ 2.25
Gross proceeds subsequent           $ 467,120      
Stock based compensation           561,246   $ 1,760,234  
Unrecognized stock based compensation expense related to stock option         $ 287,148 $ 287,148      
Unrecognized stock option weighted average remaining vesting period           1 year 1 month 6 days      
Stock option exercise price per share         $ 0.14 $ 0.14   $ 1.04  
Other expense           $ 5,827      
Issued shares exchange for cash           $ (45,000)      
Number of fully vested common stock shares issued         101,962 101,962      
Former Members [Member]                  
Number of shares returned to former members         242,303        
Issued shares exchange for cash         $ 45,000        
Purchaser [Member] | Securities Purchase Agreements [Member]                  
Net proceeds from issuance costs   $ 85,285              
Gross proceeds from issuance costs   99,960              
Issuance costs   14,675              
Accrued expenses         9,677 $ 9,677      
Derivative liabilities         $ 88,973 $ 88,973      
Issuance of warrants         7,786 7,786      
Series A Convertible Preferred Stock [Member]                  
Preferred stock shares issued 500,000       11,000,000 11,000,000 10,500,000    
Fair value of issue shares $ 500,000                
Series B Convertible Preferred Stock [Member]                  
Preferred stock shares issued         8,250 8,250 8,250    
Preferred stock liquidation preference         $ 825,000 $ 825,000      
Series C Convertible Preferred Stock [Member]                  
Preferred stock shares issued         142,640 142,640 120,330    
Fair value of issue shares $ 75,000                
Preferred stock liquidation preference   14,264,000              
Preferred stock aggregate subscription amount   2,900,040              
Cash payment of settlement   650,040              
Remaining amount   $ 2,250,000              
Net proceeds from issuance costs         $ 680,830 $ 680,830      
Gross proceeds from issuance costs         800,040 800,040      
Issuance costs         119,210 119,210      
Accrued expenses         $ 79,208 $ 79,208      
convertible preferred shares   13,334              
Number of warrants issued to purchase of common stock shares   238,000     1,112,190 1,112,190      
Warrants exercise price per share   $ 1.00     $ 1.00 $ 1.00      
Derivative liabilities   $ 10,458              
Number of preferred stock shares issued in satisfaction of liability   1,666              
Number of shares issued during period 750         2,932 3,184    
Payment of dividends           $ 318,400 $ 293,200    
Stock based compensation             $ 842,229    
Series C Convertible Preferred Stock [Member] | Board of Directors [Member]                  
Fair value of issue shares           $ 39,964      
Number of shares issued during period           444